Incomplete and inconsistent capture of information about race and ethnicity in real-world data (RWD) limits a full understanding of the distribution, safety, and effectiveness of FDA-regulated products, which impacts the health of the public.

The Reagan-Udall Foundation for the FDA, in collaboration with FDA's Office of Minority Health and Health Equity, launched RAISE to elevate the capture and curation of race and ethnicity data in health care settings to ultimately improve the quality of health care and medical products.

Speaker biographies

AGENDA

Welcome 
        Speaker: Susan C. Winckler RPh, Esq, Reagan-Udall Foundation for the FDA

Welcome Remarks from FDA
        Speaker: RDML Richardae Araojo, PharmD, MS, U.S. Food and Drug Administration
                       

Presentations 

       Barriers, Facilitators, and Potential Solutions
       Alecia Clary, PhD, MSW
       Founder and President, Evidence to Practice
       Co-Investigator, RAISE

Moderated Discussion 
         Moderator: Susan C. Winckler RPh, Esq
                           
         Discussants:
         Oscar Benavidez, MD, MBA, MPP, Massachusetts General Hospital
         Elise Berliner, PhD, Cerner Enviza
         Louis Cabanilla, MSc, Point 32 Health
         Alecia Clary, PhD, MSW, Evidence to Practice
         Rachele Hendricks-Sturrup, DHSc, MSc, MA, Duke Margolis Center for Health Policy 
         Sandy Leonard, COTA, Inc.

   
Adjourn